177 related articles for article (PubMed ID: 25778435)
21. Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.
Kato S; Liberona MF; Cerda-Infante J; Sánchez M; Henríquez J; Bizama C; Bravo ML; Gonzalez P; Gejman R; Brañes J; García K; Ibañez C; Owen GI; Roa JC; Montecinos V; Cuello MA
Endocr Relat Cancer; 2018 Oct; 25(10):821-836. PubMed ID: 29848667
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
[TBL] [Abstract][Full Text] [Related]
23. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
Rybak AP; He L; Kapoor A; Cutz JC; Tang D
Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of statins as a treatment for ovarian cancer.
Robinson E; Nandi M; Wilkinson LL; Arrowsmith DM; Curtis AD; Richardson A
Gynecol Oncol; 2013 May; 129(2):417-24. PubMed ID: 23402903
[TBL] [Abstract][Full Text] [Related]
26. Identification of tumor-initiating cells derived from two canine rhabdomyosarcoma cell lines.
Kishimoto TE; Yashima S; Nakahira R; Onozawa E; Azakami D; Ujike M; Ochiai K; Ishiwata T; Takahashi K; Michishita M
J Vet Med Sci; 2017 Jul; 79(7):1155-1162. PubMed ID: 28529244
[TBL] [Abstract][Full Text] [Related]
27. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
28. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
[TBL] [Abstract][Full Text] [Related]
30. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
[TBL] [Abstract][Full Text] [Related]
32. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms.
Tamura D; Saito T; Murata K; Kawashima M; Asano R
Int J Oncol; 2015 Mar; 46(3):1393-404. PubMed ID: 25571853
[TBL] [Abstract][Full Text] [Related]
35. Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells.
Kobayashi K; Baba K; Kambayashi S; Okuda M
Res Vet Sci; 2024 Mar; 169():105174. PubMed ID: 38340381
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin inhibits the proliferation of A549 lung cancer cells through oxidative stress and up-regulation of SOD2.
Li Y; Fu J; Yuan X; Hu C
Pharmazie; 2014 Aug; 69(8):610-4. PubMed ID: 25158572
[TBL] [Abstract][Full Text] [Related]
37. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
38. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment.
Kubatka P; Kajo K; Zihlavnikova K; Adamicova K; Vybohova D; Pec M; Nosal V; Stollarova N; Bojkova B; Kassayova M; Orendas P
Neoplasma; 2012; 59(5):516-23. PubMed ID: 22668016
[TBL] [Abstract][Full Text] [Related]
40. Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.
Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL
Eur J Pharmacol; 2011 Dec; 673(1-3):96-100. PubMed ID: 22040920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]